Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 190

1. RETRACTION: Identification of VLDL as a Biomarker for Prewarning of Androgenic Alopecia Skin Research and Technology · 2026
2. Identification of VLDL as a biomarker for prewarning of androgenic alopecia Skin research and technology · 2024
3. Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight Clinical Endocrinology · 2011 · 28 citations
4. Lipid Profile and Metabolic Syndrome Status in Patients with Oral Lichen Planus, Oral Lichenoid Reaction and Healthy Individuals Attending a Dental College in Northern India - A Descriptive Study Journal of Clinical and Diagnostic Research · 2014 · 17 citations
5. Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review Hormone and Metabolic Research · 2019 · 16 citations
6. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? Journal of Obstetrics and Gynaecology Research · 2007 · 16 citations
7. Metabolic Effect at Six and Twelve Months of Cyproterone Acetate (2 mg) Combined with Ethinyl Estradiol (35 μg) in 31 Patients Hormone and Metabolic Research · 1990 · 8 citations
8. Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: A case-control study Journal of Obstetrics and Gynaecology Research · 2014 · 5 citations
9. RETRACTED: Serum lipids may causally affect the occurrence of alopecia areata: A Mendelian randomization study Skin Research and Technology · 2024 · 3 citations
10. Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome International journal of reproduction, contraception, obstetrics and gynecology · 2017 · 1 citations

Community

— no results